Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell membranes and cell walls of oropharyngeal pathogens, including bacteria like Streptococcus pyogenes and fungi like Candida albicans, serve as essential structural barriers and metabolic interfaces. The bacterial cell wall is primarily composed of a peptidoglycan meshwork that provides mechanical strength and protects the organism from osmotic lysis (StatPearls, 2023). In contrast, fungal pathogens possess a cell wall containing chitin and glucans, with a cytoplasmic membrane rich in ergosterol that maintains fluidity and structural integrity (NIH, 2022). These structures are primary targets for therapeutic agents; for example, beta-lactam antibiotics interfere with the transpeptidation of peptidoglycan, leading to cell wall weakening and subsequent bacterial death (PubMed, 2021). Antiseptic compounds such as chlorhexidine and cetylpyridinium chloride target the microbial membrane by interacting with negatively charged phospholipids, causing physical disruption and the leakage of vital intracellular contents (Journal of Oral Microbiology, 2020). Effective targeting of these components is critical for treating common oropharyngeal infections like pharyngitis and oral candidiasis, although clinicians must manage the risk of promoting antimicrobial resistance and disrupting the host's protective commensal flora (Microbiology Society, 2021).
Inhibition of peptidoglycan cross-linking, disruption of lipid bilayer integrity, and inhibition of cell wall component synthesis (e.g., beta-glucans or ergosterol).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membranes and cell walls of oropharyngeal pathogens.